Based on the AAP guidelines, an infant was categorized as LR-BRUE, HR-BRUE, or "not having a BRUE" (NOT-BRUE). 1 BRUE was defined as a brief event (duration less than 1 min), resolved
(not present at the moment of the clinical evaluation), unexplained (good clinical condition, normal clinical examination, clinical history not concerning), with at least one of the following: (1) cyanosis or pallor; (2) absent, decreased, or irregular breathing; (3) marked change in tone (hyper-or hypotonia); and (4) Gastroenterology. During the entire study interval, the Hospital practice was to admit all infants presenting with an ALTE. All patients in this series were admitted to the general Pediatric ward service. Sub-specialist consultation was obtained as deemed appropriate.
Italy has a public national healthcare service with universal coverage available to all citizens with public and private components.
Emergency medical services are free of charge for children under 14 years of age. The government reimburses hospitals for in-patient care based on a diagnostic related grouping (DRG) system. The cost of individual diagnostic testing and the length of stay for a given hospitalization are not considered. 
| Statistical analysis

| RESULTS
During the study period 12 582 patients were discharged from our pediatric ward, 3292 were less than 1 year of age, and 372 had at least one of the searched diagnostic codes. After reviewing the clinical records, 86 patients were identified with an ALTE, but 2 were excluded because the duration of the event was not specified. Thus, 84 patients were included in our analyses.
Thirty-five infants with ALTE were excluded as a BRUE for the following reasons (some had more than one exclusion); 23 had Thirty-three of the BRUE patients met the higher-risk criteria for the following reasons; 18 were less than 60 days, 2 were premature, 2 had a previous LR-BRUE, 4 had a previous HR-BRUE, and 7 had a cluster of events. Thus, 16 were LR-BRUE, 33 were HR-BRUE, and 35
were Not-BRUE. The demographic, diagnostic, and cost data is presented in Table 1 One LR-BRUE patient experienced another BRUE during the hospitalization. This infant had a Neurology consultation and a normal EEG initially, but was diagnosed with a seizure disorder 1 month later.
All patients with LR-BRUE has prospective telephone follow-up. After follow-up, 2 patients had been diagnosed with gastroesophageal reflux, 1 patent foramen ovale, 1 subsequently developed seizures, and 12 had no additional medical diagnosis. There were no deaths in any of the groups.
There was no significant difference in the average hospital stay or the cost per patient between the groups. Because reimbursement is based on a DRG, cost-savings had the LR-BRUE group not been admitted is the cost for the LR-BRUE group divided the total cost for all The heterogeneity of the ALTE diagnosis has hampered efforts to make evidence-based recommendations regarding management.
Some reports have advocated routinely performing a complete blood count, 6 chest x-ray, 7 urine analysis, 7 swallowing studies, 8 and pH monitoring. 9 Several reports also indicate a high incidence of nonaccidental trauma in ALTE infants mandating additional testing.
10,11
Most groups advocate a limited work-up with selected hospitalization, 12 but others have advocated a comprehensive in-patient work-up on all infants presenting with ALTE. further validating the AAP guideline approach to add specificity to the new BRUE diagnosis that will facilitate evidence-based studies to refine the management of the BRUE population going forward.
According to the AAP guidelines, LR-BRUE infants do not require admission if they appear well after brief monitoring with a pulse oximeter and serial observations. Thus, we evaluated the potential cost-savings if our LR-BRUE had not been admitted, resulting in considerable decreases in diagnostic testing and in-patient costs with no additional morbidity or mortality. In addition to the decreases in expenditure, there would be less anxiety-provoking testing, risk of hospital-acquired infections, and possible false positive results.
Importantly, one patient with LR-BRUE has a second BRUE and, COLOMBO ET AL. 
